Chlorambucil
⚠️ Patient Safety Alert:
Patients on chlorambucil should seek urgent medical advice if their temperature rises above 37.5°C (99.5°F) or 38°C (100.4°F), or if they feel unwell (e.g. chills, sore throat, cough, diarrhoea, urinary frequency).
👉 Even minor infections can escalate rapidly due to myelosuppression.
💊 About
- Chlorambucil is an oral alkylating agent used mainly in haematological malignancies.
- Causes DNA cross-linking and strand breaks, preventing replication and triggering apoptosis.
- Always check the BNF entry before prescribing.
⚙️ Mode of Action
- Binds covalently to DNA bases → causes cross-links and mispairing.
- Cell cycle non-specific but preferentially affects rapidly dividing cells.
🎯 Indications / Dose
- Dosing is specialist-led and given orally.
- Hodgkin’s disease.
- Non-Hodgkin’s lymphoma (selected types).
- Chronic lymphocytic leukaemia (CLL).
- Waldenström’s macroglobulinaemia.
🤝 Interactions
- See BNF for full details.
- Other myelosuppressive or immunosuppressive drugs increase toxicity risk.
⚠️ Cautions
- Oral anti-cancer medicines carry a high risk of dosing errors → doses must be double-checked.
- Monitor full blood counts closely.
- Carcinogenic potential with long-term use (risk of secondary malignancies).
🚫 Contraindications
- Refer to BNF for full list.
- Severe bone marrow suppression and active infection are key contraindications.
❗ Side Effects
- Common: Anaemia, neutropenia, thrombocytopenia, nausea, vomiting, diarrhoea, oral ulcers.
- Serious: Stevens–Johnson syndrome, infertility, seizures, secondary malignancies.
- Long-term: risk of myelodysplastic syndrome or acute leukaemia.
📚 References